A short description of the available technology.

We have developed a technology, which relates to an enriched extract and single active compound from rooibos tea. This compound has a demonstrable effect against a variety of metabolic disorders, a major worldwide health threat. The SAMRC has generated substantial in vitro and in vivo data on the potential health benefits of the compound and extract and has developed a synthetic method for the production of the active ingredient."

Keywords related to the available technology.
Intellectual Property Protection: 
Relevant intellectual property protection in place for this technology.
Market need/opportunity: 
Brief description of the technology’s market need.

Aspalathus linearis, commonly known as rooibos, is well known for its various health properties, some of which include antioxidant and stress-lowering properties. Rooibos is also rich in polyphenols and is the only plant known to contain the phenolic antioxidant, aspalathin. The aspalathin content of the rooibos plant varies depending on a number of factors, and its concentrations within the plant material is diminished during the fermentation process, which is necessary as the oxidation process results in the characteristic red-brown colour and aromatic flavour. Unfermented (green) rooibos, which is not oxidised, contains much higher levels of aspalathin than the fermented rooibos, this product is commonly prepared as a herbal tea.
Metabolic disorders are commonplace and have dire medical consequences, antioxidants may be able to mitigate the development and consequences of metabolic disorders.

Value proposition/benefits: 
Brief description of the technology’s benefits.

The SAMRC and the Agricultural Research Council (ARC) have developed a method for the production of aspalathin-enriched green rooibos extract (GRT Extract), containing a minimum of 12% aspalathin, and having a number of beneficial effects in the management of conditions linked to glucose and lipid metabolism. The beneficial effects of aspalathin and aspalathin-rich green rooibos extracts (ARC2 and Afriplex GRT) are based on current and previous research conducted by the SAMRC and others.

Team and expertise: 
The team and expertise behind the technology.

The SAMRC and the Agricultural Research Council (ARC) developed the production method for the GRT Extract together.

Opportunity type: 
What is the technology owner looking for? E.g. collaboration, investment, sales, etc.
Organisation sector: 
The technology was developed by an organisation in the following sector(s).
The industry(s) relevant to the technology. Which industries can benefit from this technology?
Technological area: 
The technology area relevant to the technology.
Technology Readiness Level: 
The Technology Readiness Level of the available technology. For more information on the Technology Readiness Levels, please follow the link: Technology Readiness Levels
The country in which the technology is/was developed.
The city where the technology developers are based.

Cape Town

Represented organisation or individual: 
The individual or organisation behind the technology.
Use this link to see more information on this technology.
Reference number: 
Use this reference number to easily find the technology in future.